Eli Lilly and Company LLY.TO
48.67 CAD -1.87 (-3.70%)
Nov 5, 2026, 3:59 PM EST
48.67 Day range 51.69
30.67 52-week range 51.69
- YTD
- +24.54%
- 1 year
- +24.54%
- Market cap
- 1.59T
- Profit margin
- 33.53%
- EPS (ttm)
- 1.09
- P/E ratio
- 44.65
- YTD return
- +24.54%
- 1-year return
- +24.54%
- Volume
- 125.56K
- Avg volume
- 82.86K
- Open
- 50.92
- Previous close
- 50.54
- Day's range
- 48.67 – 51.69
- 52-week range
- 30.67 – 51.69
1M +7.57 (+18.32%)
Key statistics
- Enterprise value
- 1.15T
- PEG ratio
- 0.42
- Price / sales
- 0.00
- Price / book
- 30.79
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Total cash
- 0
- Total debt
- 62
- Return on equity
- 92.58%
- 50-day average
- 43.03
- 200-day average
- 39.35
Next earnings
Consensus EPS estimate 0.00.
About Eli Lilly and Company
Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products include diabetes, oncology, immunology, neuroscience, and other products and therapies. The company was founded by Eli Lilly on May 10, 1876 and is headquartered in Indianapolis, IN.
- Sector
- Healthcare
- Industry
- Medical - Pharmaceuticals
- Country
- US
- Employees
- 50,000
- Website
- lilly.com
News
No recent headlines
Headlines appear here as they are published.
Your note
Sign in to keep a note on LLY.TO — it syncs with the Stock Master app.